+971.7%
MRNA vs BP
+65.8%
+905.8%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | BP | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.3% | -0.1% | +1.4% | +1.3% |
| 7D | -13.8% | -4.6% | -9.2% | -13.9% |
| 30D | -17.7% | -11.5% | -6.2% | -17.8% |
| 3M | +14.3% | -0.1% | +14.4% | +14.2% |
| 6M | +336.0% | -4.1% | +340.1% | +336.3% |
| YTD | +575.9% | +30.5% | +545.4% | +571.2% |
| 1Y | +724.4% | +26.1% | +698.3% | +718.9% |
| 3Y | +160.8% | +42.5% | +118.3% | +157.0% |
| 5Y | -24.4% | +111.3% | -135.7% | -21.9% |
| All | +971.7% | +65.8% | +905.8% | +1,227.0% |
Cumulative growth
Daily Returns
Daily percentage return beside BP.
Daily Out/Under-Performance
Portfolio return minus BP return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded BP wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling